Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism
Authors:
- 1 June 2015
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 100 (6) , 2396-2404
Abstract
Hypertension is associated with higher PTH levels, and specific antihypertensive medications may modulate PTH. Whether hypertension or the use of specific antihypertensive medications influences the risk of developing incident primary hyperparathyroidism (P-HPTH) is not known. The purpose of this study was to investigate whether a history of hypertension and the use of specific antihypertensive medications determine the risk for developing P-HPTH in a large prospective study. A longitudinal prospective cohort of female nurses in the Nurses' Health Study I (n = 75 600), who did not have P-HPTH at baseline and completed a questionnaire assessment of lifetime history of P-HPTH were followed from 1986 to 2008. Most participants were white and postmenopausal. The study was a nationwide cohort study. Incident P-HPTH was assessed initially via questionnaire and then was confirmed by medical record review. Cox proportional hazards models were used to adjust for potential confounders. We documented 347 incident cases of P-HPTH during 1 719 416 person-years of follow-up. The age-adjusted relative risk (RR) for incident P-HPTH associated with hypertension was 1.80 (95% confidence interval [CI], 1.43-2.26), and the multivariate-adjusted RR was 1.45 (95% CI, 1.10-1.91). Among participants with a history of hypertension, the use of furosemide, when compared with the use of other antihypertensive medications, was associated with increased risk for developing P-HPTH; age-adjusted RR for incident P-HPTH was 1.79 (95% CI, 1.15-2.79) and multivariate-adjusted RR was 1.71 (95% CI, 1.08-2.71). In a large longitudinal prospective cohort study of mostly older white women, a history of hypertension and use of furosemide were associated with a significantly higher risk of developing P-HPTH.Keywords
This publication has 55 references indexed in Scilit:
- Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohortsBritish Journal of Nutrition, 2012
- Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency CohortNephrology Dialysis Transplantation, 2011
- A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-IIJournal Of Hypertension, 2010
- Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the CommunityCirculation, 2009
- The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 YearsThe Journal of Clinical Endocrinology & Metabolism, 2008
- A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid SurgeryNew England Journal of Medicine, 1999
- Reproducibility and Validity of a Self-Administered Physical Activity QuestionnaireInternational Journal of Epidemiology, 1994
- Validity of Self-Reported Waist and Hip Circumferences in Men and WomenEpidemiology, 1990
- REPRODUCIBILITY AND VALIDITY OF SELF-REPORTED MENOPAUSAL STATUS IN A PROSPECTIVE COHORT STUDYAmerican Journal of Epidemiology, 1987
- Sensitivity of the Parathyroid Hormone–1, 25-Dihydroxyvitamin D Axis to Variations in Calcium Intake in Patients with Primary HyperparathyroidismNew England Journal of Medicine, 1985